XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Total revenue $ 3,437 $ 0 $ 5,744 $ 120
Operating expenses        
Selling, general and administrative 10,006 830 19,154 1,393
Research and development 7,726 3,045 14,519 6,689
Cost of goods sold 341 0 520 0
Impairment of acquired contract intangible asset 3,724 0 3,724 0
Total operating expenses 21,797 3,875 37,917 8,082
Loss from operations (18,360) (3,875) (32,173) (7,962)
Other income (expense)        
Change in fair value of convertible promissory notes 0 2,371 0 1,206
Gain upon extinguishment of debt 0 196 0 196
Interest income 158 1 171 1
Interest expense (58) (227) (115) (451)
Total other income, net 100 2,341 56 952
Loss before income tax expense (18,260) (1,534) (32,117) (7,010)
Income tax expense (9) (2) (9) (2)
Net loss $ (18,269) $ (1,536) $ (32,126) $ (7,012)
Net loss per share attributable to common stockholders, basic $ (0.87) $ (0.60) $ (1.53) $ (2.76)
Net loss per share attributable to common stockholders, diluted $ (0.87) $ (0.60) $ (1.53) $ (2.76)
Weighted average number of common shares outstanding used in computing net loss per share attributable to common stockholders, basic 20,970,459 2,542,358 20,942,804 2,542,358
Weighted average number of common shares outstanding used in computing net loss per share attributable to common stockholders, diluted 20,970,459 2,542,358 20,942,804 2,542,358
Product sales, net        
Total revenue $ 3,437 $ 0 $ 5,744 $ 0
Grant revenue        
Total revenue $ 0 $ 0 $ 0 $ 120